ELTX

Elicio Therapeutics, Inc.

• TipRanks·03/17 12:15

  Elicio Therapeutics reports inducement grants

• Reuters·03/17 12:02

  Elicio Therapeutics reports 1,600 inducement stock options priced at USD 12.16 per share

• TipRanks·03/16 14:05

  Elicio Therapeutics Launches New $100 Million ATM Program

• Benzinga·03/16 13:29

  Elicio Therapeutics Launches $100M At-The-Market Offering Program, Replaces Prior $40M Sales Agreement

• Reuters·03/16 13:20

  Elicio Therapeutics signs ATM equity distribution agreement for up to USD 100 million

• Reuters·03/16 13:20

  ELICIO THERAPEUTICS INC FILES FOR OFFERING OF UP TO $100 MLN COMMON STOCK - SEC FILING

• Dow Jones·03/13 11:26

  Elicio Therapeutics Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·03/13 11:26

  Elicio Therapeutics Price Target Raised to $17.00/Share From $13.00 by HC Wainwright & Co.

• Benzinga·03/13 11:16

  HC Wainwright & Co. Maintains Buy on Elicio Therapeutics, Raises Price Target to $17

• TipRanks·03/13 10:30

  Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), Silence Therapeutics (SLN)

• TipRanks·03/13 10:15

  Elicio Therapeutics price target raised to $17 from $13 at H.C. Wainwright

• Reuters·03/13 10:11

  ELICIO THERAPEUTICS, INC. <ELTX.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $17 FROM $13

• Reuters·03/13 07:25

  U.S. RESEARCH ROUNDUP-Adobe, KLA, Ulta Beauty

• Seeking Alpha·03/12 21:20

  Elicio Therapeutics reports FY GAAP EPS of -$2.58

• Dow Jones·03/12 20:39

  *Elicio Therapeutics Sees Funding Sufficient Into 3Q26 >ELTX